ANAVEX2-73 for Treatment of Early Alzheimer's Disease

Clinical trial NCT03790709 · COMPLETED

Trial details

NCT number: NCT03790709
Sponsor: Anavex Life Sciences Corp.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2018-07-03
Primary completion: 2022-06-30
Enrollment: 509

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.